Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients
Status:
Enrolling by invitation
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The overall objective of this trial is to provide aftercare treatment with Lamazym and to
evaluate the safety of repeated Lamzede i.v. treatment of subjects with alpha-Mannosidosis.